Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| CATX | PERSPECTIVE THERAPEUTICS INC | $198.48M | 74,337,990 | 26.50% | 73.50% | Net Buying | Net Buying | ||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | 71,358,638 | 40.58% | 59.42% | Net Buying | Net Buying | ||
| MNPR | MONOPAR THERAPEUTICS | $498.55M | 6,682,584 | 18.47% | 81.53% | Net Selling | Net Selling | ||
| NKLR | TERRA INNOVATUM GLOBAL NV | $400.72M | 70,300,948 | 20.37% | 0.00% | ||||
| OLMA | OLEMA PHARMACEUTICALS INC | $2.27B | 68,659,923 | 72.63% | 27.37% | Net Buying | Net Buying | ||
| NTSK | NETSKOPE INC | $8.15B | 393,258,861 | 35.83% | 11.95% | Net Buying | Net Buying | ||
| ZURA | ZURA BIO LTD | $261.39M | 65,023,308 | 49.27% | 50.73% | ||||
| RWT | REDWOOD TRUST INC | $709.42M | 126,682,210 | 76.56% | 4.32% | Net Buying | |||
| PRCH | PORCH GROUP INC | $1.23B | 123,683,561 | 61.81% | 38.19% | Net Selling | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.44B | 47,661,138 | 75.33% | 24.67% | Net Selling | Net Selling | ||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.26B | 139,636,593 | 45.44% | 54.56% | Net Selling | Net Buying | ||
| AVBP | ARRIVENT BIOPHARMA INC | $1.01B | 41,281,361 | 78.59% | 21.41% | Net Buying | |||
| FUFU | BITFUFU INC | $469.42M | 164,131,946 | 0.62% | 2.07% | ||||
| DNTH | DIANTHUS THERAPEUTICS INC | $1.81B | 42,876,015 | 58.17% | 41.83% | Net Buying | Net Buying | ||
| SSTI | SOUNDTHINKING INC | $96.38M | 12,698,453 | 58.20% | 34.82% | Net Selling | Net Selling | ||
| CBIO | CRESCENT BIOPHARMA INC | $195.75M | 13,892,516 | 13.42% | 86.58% | Net Buying | Net Buying | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $3.56B | 134,447,836 | 90.30% | 9.70% | Net Selling | Net Selling | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.58B | 59,547,781 | 35.04% | 4.41% | Net Buying | |||
| VNCE | VINCE HOLDING CORP | $46.69M | 13,339,426 | 0.20% | 99.80% | Net Selling | |||
| TRVI | TREVI THERAPEUTICS INC | $1.64B | 128,230,134 | 41.41% | 58.59% | Net Buying | Net Buying | ||
| KYTX | KYVERNA THERAPEUTICS INC | $384.53M | 43,796,170 | 50.31% | 49.69% | ||||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $254.66M | 56,464,731 | 39.63% | 60.37% | Net Buying | Net Selling | ||
| IVA | INVENTIVA SA | $426.65M | 95,662,391 | 5.34% | 0.00% | ||||
| SAIL | SAILPOINT INC | $11.81B | 561,625,760 | 52.88% | 47.12% | Net Selling | Net Selling | ||
| COYA | COYA THERAPEUTICS INC | $129.31M | 20,924,456 | 22.73% | 10.32% | Net Buying | |||
| JANX | JANUX THERAPEUTICS INC | $920.26M | 60,147,807 | 63.29% | 36.71% | Net Buying | Net Buying | ||
| MPLT | MAPLIGHT THERAPEUTICS INC | $939.22M | 45,373,033 | 0.00% | 53.72% | Net Buying | Net Buying | ||
| Q | QNITY ELECTRONICS INC | $16.54B | 209,463,194 | 0.00% | 0.11% | Net Buying | Net Buying | ||
| PYPD | POLYPID LTD | $61.36M | 15,654,129 | 18.10% | 0.00% | ||||
| NUVL | NUVALENT INC | $7.62B | 72,706,715 | 75.85% | 24.15% | Net Selling | Net Selling | ||
| MRP | MILLROSE PROPERTIES INC | $5.26B | 166,003,497 | 64.26% | 0.24% | Net Buying | Net Buying | ||
| PRQR | PROQR THERAPEUTICS NV | $250.97M | 107,710,916 | 34.86% | 0.00% | ||||
| BRSL | BRIGHTSTAR LOTTERY PLC | $3.11B | 195,000,000 | 44.92% | 0.00% | ||||
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $16.20B | 256,096,379 | 77.58% | 22.42% | Net Buying | Net Buying | ||
| DCO | DUCOMMUN INC | $1.41B | 14,946,052 | 88.54% | 10.35% | Net Selling | Net Selling | ||
| CRC | CALIFORNIA RESOURCES CORP | $4.04B | 83,711,931 | 87.77% | 12.23% | Net Selling | Net Buying | ||
| JBIO | JADE BIOSCIENCES INC | $689.14M | 46,004,205 | 62.53% | 37.47% | Net Buying | Net Buying | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $76.51M | 115,058,619 | 8.25% | 9.28% | ||||
| EVMN | EVOMMUNE INC | $567.75M | 31,524,093 | 0.00% | 49.18% | Net Buying | Net Buying | ||
| PTRN | PATTERN GROUP INC | $2.24B | 176,224,923 | 11.52% | 88.48% | Net Selling | Net Selling | ||
| LXEO | LEXEO THERAPEUTICS INC | $713.09M | 72,987,327 | 67.63% | 9.87% | Net Selling | Net Selling | ||
| GPCR | STRUCTURE THERAPEUTICS INC | $4.06B | 182,032,920 | 31.11% | 11.89% | Net Selling | Net Selling | ||
| SNTI | SENTI BIOSCIENCES INC | $34.44M | 26,290,838 | 18.58% | 81.42% | Net Buying | |||
| VREX | VAREX IMAGING CORP | $488.31M | 41,700,000 | 93.34% | 1.83% | Net Selling | Net Selling | ||
| VKTX | VIKING THERAPEUTICS INC | $4.19B | 113,036,344 | 63.00% | 8.97% | Net Selling | Net Selling | ||
| DYN | DYNE THERAPEUTICS INC | $2.75B | 142,824,687 | 83.29% | 16.71% | Net Buying | Net Selling | ||
| CMPS | COMPASS PATHWAYS PLC | $647.15M | 96,017,044 | 57.78% | 29.77% | Net Selling | |||
| NXTC | NEXTCURE INC | $29.85M | 2,679,822 | 5.64% | 94.36% | ||||
| NRIX | NURIX THERAPEUTICS INC | $1.47B | 76,883,436 | 90.92% | 9.08% | Net Selling | Net Selling | ||
| OVID | OVID THERAPEUTICS INC | $116.79M | 71,212,353 | 50.85% | 25.78% | Net Selling | |||
| AMPL | AMPLITUDE INC | $1.50B | 133,686,174 | 53.65% | 46.35% | Net Selling | Net Selling | ||
| ENOV | ENOVIS CORP | $1.51B | 57,189,381 | 42.12% | 57.88% | Net Selling | Net Buying | ||
| BEP | BROOKFIELD RENEWABLE PARTNERS LP | $7.95B | 285,180,371 | 58.86% | 0.00% | ||||
| ORKA | ORUKA THERAPEUTICS INC | $1.46B | 48,409,232 | 22.87% | 77.13% | Net Buying | Net Buying | ||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $139.76M | 55,903,513 | 2.90% | 0.00% | ||||
| RZLT | REZOLUTE INC | $166.91M | 92,727,532 | 44.67% | 55.33% | Net Buying | |||
| ANGO | ANGIODYNAMICS INC | $541.37M | 41,199,844 | 79.94% | 20.06% | Net Selling | Net Buying | ||
| PVLA | PALVELLA THERAPEUTICS INC | $1.17B | 11,836,490 | 57.88% | 42.12% | Net Buying | Net Buying | ||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | 97,389,279 | 83.32% | 16.68% | Net Selling | Net Selling | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.00B | 59,347,317 | 49.50% | 50.50% | Net Selling | Net Selling | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.59B | 210,543,224 | 83.90% | 16.10% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.